Skip to contentI
Inspire Medical Systems, Inc.
I
INSPInspire Medical Systems, Inc. Q2 2023 · 10-Q
Revenue$151.09M$151.09M+65.3% vs Q2 2022 Net Income-$11.95M-$11.95MN/M vs Q2 2022 EPS Diluted-$0.41-$0.41N/M vs Q2 2022 Gross Profit$126,840,000+64.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Inspire Medical Systems, Inc. · CIK 1609550 · Engraved from SEC EDGAR
Operating Cash Flowderived$5,092,000N/M Free Cash Flowderived$237,000N/M Margins · derivedGross margin83.9%−0.5 pt vs Q2 2022
Operating margin-11.0%+4.3 pt vs Q2 2022
Net margin-7.9%+7.9 pt vs Q2 2022
ended Jun 30, 2023 · filed Aug 1, 2023 · 32 d after period end